Autopsy report · NCT00973271

Diazoxide Choline Controlled-Release Tablet (DCCR) for Very High Triglycerides

Cause of deathFunding or business Automatic label, confidence 0.5, unverified. How labels are made.

“Did not continue with development of DCCR in Very High Triglycerides”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 3
Sponsor: Essentialis, Inc.
Sponsor type: Industry
Conditions: Hypertriglyceridemia
Interventions: 290 mg DCCR; 435 mg DCCR; 135 mg fenofibric acid; Placebo; atorvastatin
Participants: 0

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.